Dr. Peter C. Kurniali, MD

Dr. Kurniali practices at Sanford Medical Center - Bismarck in Bismarck, North Dakota.

Dr. Kurniali's NPI, 1922236793, was assigned on June 30, 2009. Dr. Kurniali graduated from Other in 2006. Dr. Kurniali holds North Dakota license 13565.

Dr. Kurniali's primary practice is Sanford Medical Center - Bismarck, at 300 N 7th St, Bismarck, ND 58501 in Burleigh County. The practice phone is (701) 323-6000.

Dr. Kurniali's primary practice is Sanford Medical Center - Bismarck in Bismarck, North Dakota. Dr. Kurniali is also affiliated with Sanford Bismarck Medical Center. The medical group on file is Sanford Bismarck Medical Center. Dmand AI also links Dr. Kurniali to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kurniali practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kurniali's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kurniali is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kurniali's licenses on file in 4 states: North Dakota, Michigan, Texas and Rhode Island.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Kurniali treats.

CMS data shows 2,372 Medicare services from Dr. Kurniali across 8 procedure codes in 2024, for 627 Medicare patients. Medicare paid $196,404 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 627 Medicare patients who saw Dr. Kurniali in 2024. The largest group is 65 to 74, with 298 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kurniali's median patient age at 74, with 47% women.

In 2024, Dr. Kurniali wrote 2,065 Medicare Part D claims for 292 patients. 70% of them were for generic drugs. CMS names the drug for 1,832 of them, across 38 drugs with 11 or more claims each, at $4,526,306 in total drug cost. In 2023, CMS named 1,538 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kurniali for performance year 2024, reported through an alternative payment model (APM). Dr. Kurniali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Kurniali, published from 2011 to 2023. 2014 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents. Dr. Kurniali's most frequent co-authors are Anas Al-Janadi, MD, Jonathan S. Bleeker, MD and Zhaohui Jin, MD.

CMS Open Payments shows 387 general payments to Dr. Kurniali from 72 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Incyte Corporation paid the most, $1,874.

Dr. Kurniali graduated from Other in 2006.

Dr. Kurniali is in network with 16 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.